Rachel Fremont
Overview
Explore the profile of Rachel Fremont including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
643
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sejourne C, Barker M, Heath M, Gazes Y, Fremont R, Perez Y, et al.
J Alzheimers Dis Rep
. 2025 Mar;
9:25424823251324391.
PMID: 40034531
Background: Non-Alzheimer's disease dementias, including frontotemporal dementia (FTD) can be difficult to characterize due to the predominance of distinct behavioral and neuropsychiatric symptoms. Widely used measurement tools lack structure and...
2.
Fremont R, Brown O, Feder A, Murrough J
Focus (Am Psychiatr Publ)
. 2023 Jul;
21(3):257-265.
PMID: 37404968
Posttraumatic stress disorder (PTSD) is a chronic and debilitating condition. Although several psychotherapeutic and pharmacological treatments are recommended for PTSD, many individuals do not respond to treatment or respond only...
3.
Fremont R, Dworkin J, Manoochehri M, Krueger F, Huey E, Grafman J
BMJ Neurol Open
. 2022 May;
4(1):e000229.
PMID: 35519903
Background: Damage to cortico-striato-thalamo-cortical (CSTC) circuits is associated with the development of repetitive behaviours in animals and humans. However, the types of repetitive behaviours that are developed after injury to...
4.
Barker M, Cosentino S, Fremont R, Devanand D, Huey E
J Geriatr Psychiatry Neurol
. 2022 Apr;
35(6):751-762.
PMID: 35380884
Psychiatric symptoms, including changes in emotional processing, are a common feature of many neurodegenerative disorders, such as Alzheimer's disease, dementia with Lewy Bodies, frontotemporal dementia, and Huntington's disease. However, the...
5.
Fremont R, Grafman J, Huey E
Am J Alzheimers Dis Other Demen
. 2020 Jun;
35:1533317520925982.
PMID: 32519563
No abstract available.
6.
Fremont R, Manoochehri M, Armstrong N, Mattay V, Apud J, Tierney M, et al.
J Alzheimers Dis
. 2020 May;
75(4):1391-1403.
PMID: 32444540
Background: There are currently no disease-targeted treatments for cognitive or behavioral symptoms in patients with behavioral variant frontotemporal dementia (bvFTD). Objective: To determine the effect of tolcapone, a specific inhibitor...
7.
Huey E, Fremont R, Manoochehri M, Gazes Y, Lee S, Cosentino S, et al.
J Neuropsychiatry Clin Neurosci
. 2020 May;
32(4):362-369.
PMID: 32397876
Objective: The authors examined the effects of two common functional polymorphisms-brain-derived neurotrophic factor (BDNF) Val66Met and catechol--methyltransferase (COMT) Val158Met-on cognitive, neuropsychiatric, and motor symptoms and MRI findings in persons with...
8.
Barker M, Silverman H, Fremont R, Manoochehri M, Cosentino S, Huey E
Cortex
. 2020 Apr;
127:396-398.
PMID: 32291073
No abstract available.
9.
Washburn S, Fremont R, Moreno-Escobar M, Angueyra C, Khodakhah K
Elife
. 2019 Dec;
8.
PMID: 31868164
Myoclonus dystonia (DYT11) is a movement disorder caused by loss-of-function mutations in and characterized by involuntary jerking and dystonia that frequently improve after drinking alcohol. Existing transgenic mouse models of...
10.
Fremont R, Hicks C, Pincus H
Am J Geriatr Psychiatry
. 2019 Nov;
28(3):378-380.
PMID: 31704184
No abstract available.